Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast
- PMID: 17286310
- DOI: 10.1002/pd.1700
Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast
Abstract
Objective: To test the hypothesis that free fetal DNA (ffDNA) circulating in maternal plasma originates mainly from the placenta we studied ffDNA levels in anembryonic pregnancies.
Methods: Maternal blood samples were collected from 15 normal first-trimester pregnancies in which fetal sex was subsequently determined and nine patients with a diagnosis of anembryonic gestation (AG). The Y chromosome DYS14 gene was quantified by real-time quantitative PCR (RT-PCR) for the determination of fetal sex in both plasma and chorionic tissue samples. Fetal sex in chorionic tissue samples was also determined using quantitative fluorescence PCR (QF-PCR).
Results: The correct sex result was obtained from maternal plasma in all. Four AG pregnancies were female (DYS14 negative) results. In five of the AG cases, the chorionic tissue was found to be male (by both QF-PCR and RT-PCR which agreed) and positive male signal was found in maternal plasma by RT-PCR. There was no statistical difference between median free fetal DNA concentration in plasma between the AG male cases (148.3 GE/mL) and controls (145.8 GE/mL).
Conclusion: Since ffDNA levels are normal in pregnancies without a fetus, the data support the hypothesis that the trophoblastic cells are the major source ffDNA in maternal plasma.
Similar articles
-
A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.Prenat Diagn. 2006 Sep;26(9):831-6. doi: 10.1002/pd.1513. Prenat Diagn. 2006. PMID: 16832830
-
Y chromosome detection by Real Time PCR and pyrophosphorolysis-activated polymerisation using free fetal DNA isolated from maternal plasma.Prenat Diagn. 2007 Oct;27(10):932-7. doi: 10.1002/pd.1804. Prenat Diagn. 2007. PMID: 17600849
-
Strategies for the isolation and detection of fetal cells in transcervical samples.Prenat Diagn. 2002 Dec;22(12):1098-101. doi: 10.1002/pd.469. Prenat Diagn. 2002. PMID: 12454965
-
Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound.Prenat Diagn. 2006 Jul;26(7):598-603. doi: 10.1002/pd.1493. Prenat Diagn. 2006. PMID: 16856214 Review.
-
[Fetal DNA in maternal blood].Ned Tijdschr Geneeskd. 2004 Jan 24;148(4):170-4. Ned Tijdschr Geneeskd. 2004. PMID: 14974307 Review. Dutch.
Cited by
-
Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders.Clin Sci (Lond). 2022 Nov 30;136(22):1615-1629. doi: 10.1042/CS20210380. Clin Sci (Lond). 2022. PMID: 36383187 Free PMC article.
-
The application of NIPT using combinatorial probe-anchor synthesis to identify sex chromosomal aneuploidies (SCAs) in a cohort of 570 pregnancies.Mol Cytogenet. 2018 Dec 3;11:59. doi: 10.1186/s13039-018-0407-z. eCollection 2018. Mol Cytogenet. 2018. PMID: 30524505 Free PMC article.
-
The role of fetal heart rate in first trimester sonograms in prediction of fetal sex: a systematic review and meta-analysis.BMC Pregnancy Childbirth. 2023 Aug 12;23(1):582. doi: 10.1186/s12884-023-05908-8. BMC Pregnancy Childbirth. 2023. PMID: 37573392 Free PMC article.
-
Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?Clin Chem. 2014 Jan;60(1):78-87. doi: 10.1373/clinchem.2013.202663. Epub 2013 Nov 19. Clin Chem. 2014. PMID: 24255077 Free PMC article. Review.
-
Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma.J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):687. doi: 10.1007/s11596-011-0583-0. Epub 2011 Oct 25. J Huazhong Univ Sci Technolog Med Sci. 2011. PMID: 22038362
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical